Clinical and Experimental Hypertension
Published by Taylor & Francis
ISSN : 1064-1963 eISSN : 1525-6006
Abbreviation : Clin. Exp. Hypertens.
Aims & Scope
Serving as an international forum for the exchange of state-of-the-art scientific and clinical information on all aspects of human and animal hypertension, this authoritative journal publishes full articles as well as solicited and unsolicited reviews and commentaries that extend current understanding as well as facilitate the timely and successful detection, management, control, and prevention of hypertension-related conditions.
Features special issues covering proceedings of symposia on hypertension research!
Clinical and Experimental Hypertension maintains a rapid communications format that brings readers new and important research and findings in a prompt and reliable publication schedule in areas, including: antihypertensive agents circulatory control drug development and application etiology mechanisms of action neurogenic mechanisms pathophysiology pharmacological and nonpharmacological treatment and much more!
View Aims & ScopeMetrics & Ranking
Impact Factor
Year | Value |
---|---|
2025 | 3.5 |
2024 | 1.50 |
SJR (SCImago Journal Rank)
Year | Value |
---|---|
2024 | 0.729 |
Quartile
Year | Value |
---|---|
2024 | Q2 |
h-index
Year | Value |
---|---|
2024 | 57 |
Journal Rank
Year | Value |
---|---|
2024 | 7694 |
Journal Citation Indicator
Year | Value |
---|---|
2024 | 714 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Biochemistry, Genetics and Molecular Biology and Medicine, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,990.00 USD. Learn more.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
The Blood Pressure-Lowering Effect and Safety of Chlorogenic Acid from Green Coffee Bean Extract in Essential Hypertension
Citation: 197
Authors: Takuya, Yoichi, Yuki, Tatsuya, Wataru, Yasushi, Ikuo
-
Oxidative Stress in Hypertension
Citation: 147
Authors: Jacques, Rong, Hélène, Maria, Adil, Marcâ€André, Lingyun
-
Neutrophil to lymphocyte and platelet to lymphocyte ratio in patients with dipper versus non-dipper hypertension
Citation: 139
Authors: Murat, Fethullah, Erdal, Tarik, Ibrahim, Kursat, Altug
-
The Effect of Cognitive Behavior Therapy-Based “Forest Therapy†Program on Blood Pressure, Salivary Cortisol Level, and Quality of Life in Elderly Hypertensive Patients
Citation: 134
Authors: Jidong, Jong-Min, Won, Seoung-Kyeon, Eun-Joo
-
Dysregulation of Hepatic Superoxide Dismutase, Catalase and Glutathione Peroxidase in Diabetes: Response to Insulin and Antioxidant Therapies
Citation: 130
Authors: Ram K., Jaâ€Ryung, Christian K., Nosratola D.
-
The Consequences of Traumatic Brain Injury on Cerebral Blood Flow and Autoregulation: A Review
Citation: 120
Authors: Elke M., Claudia S., Robert M.